Notably, D-2hydroxyglutarate dehydrogenase (D2HGDH), which was upregulated in subtype 3, was observed to drive progression to colorectal cancer during colitis (Han et al., 2018). This evidence concerns the gene D2HGDH and colorectal cancer.